Kawasaki, Japan

Kotaro Okado



Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Kotaro Okado

Introduction

Kotaro Okado is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications. With a total of four patents to his name, Okado's work is recognized for its innovative approaches to chemical synthesis.

Latest Patents

Okado's latest patents include a method for preparing phenylalanine derivatives that feature a quinazoline-dione skeleton. This method involves several steps, including the use of a carbonyl group-introducing reagent and a specific anthranilic acid derivative. Another notable patent involves the production of crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-L-phenylalanine hydrochloride, which has been identified as useful as α4 integrin inhibitors.

Career Highlights

Kotaro Okado is affiliated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to focus on innovative research and development, contributing to advancements in drug formulation and synthesis.

Collaborations

Throughout his career, Okado has collaborated with notable colleagues, including Noriyasu Kataoka and Tatsuhiro Yamada. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Kotaro Okado's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the industry positively, paving the way for future advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…